Terms: = Head and neck cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28 AND Treatment
33 results:
1. Approach to the Patient With Parathyroid Carcinoma.
Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
[TBL] [Abstract] [Full Text] [Related]
2. Parathyroid carcinoma: molecular therapeutic targets.
Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract] [Full Text] [Related]
4. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid cancer and Atypical Parathyroid Tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
5. Para This, Fibromin That: The Role of cdc73 in Parathyroid Tumors and Familial Tumor Syndromes.
Ababneh E; Nosé V
Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
[TBL] [Abstract] [Full Text] [Related]
6. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P; Leca BM; Coelho C; Schulte KM; Gilbert J; Drakou EE; Kosmas C; Ling Chuah L; Wassati H; Miras AD; Crane J; Aylwin SJB; Grossman AB; Dimitriadis GK
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36621911
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
8. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract] [Full Text] [Related]
9. Parathyroid carcinoma: Single centre experience.
Cunha C; Pinheiro SL; Donato S; Tavares Bello C; Simões H; Nunes Silva T; Prazeres S; Doutel D; Cavaco BM; Leite V
Clin Endocrinol (Oxf); 2022 Sep; 97(3):250-257. PubMed ID: 35120263
[TBL] [Abstract] [Full Text] [Related]
10. [Sporadic primary hyperparathyroidism with multiple parathyroid adenomas].
Bibik EE; Eremkina AK; Knyazeva OA; Mokrysheva NG
Probl Endokrinol (Mosk); 2021 Nov; 67(6):31-38. PubMed ID: 35018759
[TBL] [Abstract] [Full Text] [Related]
11. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.
Cetani F; Pardi E; Marcocci C
Endocrinol Metab Clin North Am; 2021 Dec; 50(4):683-709. PubMed ID: 34774241
[TBL] [Abstract] [Full Text] [Related]
12. A Woman with a 27-Year History of Hyperparathyroidism and Hypercalcemia Who Was Diagnosed with Low-Grade Parathyroid Carcinoma.
Kaszczewska M; Popow M; Chudziński W; Kaszczewska J; Bogdańska M; Podgórska J; Czarniecka A; Gałązka Z
Am J Case Rep; 2021 Mar; 22():e930301. PubMed ID: 33707407
[TBL] [Abstract] [Full Text] [Related]
13. Parathyroid cancer: An update.
Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
[TBL] [Abstract] [Full Text] [Related]
14. Challenges in the treatment of parathyroid carcinoma: a case report.
Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
[TBL] [Abstract] [Full Text] [Related]
15. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract] [Full Text] [Related]
16. Previously unreported deletion of cdc73 involving exons 1-13 was detected in a patient with recurrent parathyroid carcinoma.
Mahajan G; Sacerdote A
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567092
[TBL] [Abstract] [Full Text] [Related]
17. Parathyroid carcinoma.
Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
[TBL] [Abstract] [Full Text] [Related]
18. Update on parathyroid carcinoma.
Cetani F; Pardi E; Marcocci C
J Endocrinol Invest; 2016 Jun; 39(6):595-606. PubMed ID: 27001435
[TBL] [Abstract] [Full Text] [Related]
19. Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Duan K; Mete Ö
Turk Patoloji Derg; 2015; 31 Suppl 1():80-97. PubMed ID: 26177319
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract] [Full Text] [Related]
[Next]